Enanta Pharmaceuticals (ENTA) Ownership - Who owns Enanta Pharmaceuticals?

Industry: @Biotechnology
17 days until earnings call

Profile

Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
303.29M
P/E Ratio
N/A
Total Cash
300.31M
Projected Growth
N/A
Total Debt
46.99M
Revenue
72.88M
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash/Share
14.18
Total Debt/Equity
N/A
Revenue/Share
3.46 USD as % of share price

Fundamentals

ENTA
Capitalization
303M
P/E Ratio
N/A
Risk (Beta)
1.01
Dividend Yield
N/A
Total Cash
300M
Total Cash/Share
14.18
Total Debt
47M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.46%
Revenue
72.9M
ROE
N/A
Book Value
166M
P/B Ratio
1.83
Cash Flow
N/A
Earnings
-6.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
212K
Current Ratio
6.43
Current Revenue Per Employee
117613.80
Dividends Per Share - Security
N/A
EBITDA
-116.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.60
Shares Held By Institutions
818M
Shares Outstanding - Current
21.2M
Total Liabilities
247M
Total Volume MTD
N/A
Value
-1
Gain YTD
52.179
View a ticker or compare two or three
ENTA
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com